Q32 Bio Inc. (FIXX) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Q32 Bio Inc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Q32 Bio Inc. (FIXX) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of -$6.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-03-10

• Q32 Bio Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was -$6.71M.
• Q32 Bio Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $41.67M, a 155.98% increase from fiscal 2022.
• Q32 Bio Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $16.28M, a 57.56% decline from fiscal 2021.
• Q32 Bio Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2021 was $38.36M.